Valuation and consulting for financial reporting, federal, state and local tax, investment and risk management purposes.Valuation Advisory
Mike is a managing director in the London office and leads the EMEA Valuation Advisory practice.
He has over 20 years of valuation and advisory experience, having started his career at PwC in 1995. He left PwC's Valuation and Strategy division in 2002 to start his own valuation business with a number of senior PwC colleagues taking advantage of the continuing move towards independent consulting advice. His business was purchased by American Appraisal in 2005.
Mike was with American Appraisal for nine years, eventually leading the Northern European and Middle East businesses. He joined Duff & Phelps following the purchase of American Appraisal in February 2015.
Mike is on the Committee of the Valuation Special Interest Group at the Institute of Chartered Accountants in England and Wales, is a Member of the Royal Institute of Chartered Surveyors' Business Valuation division, and is an active participant in driving the future of the valuation profession globally through the IVSC and other bodies. He is regularly appointed as an expert witness in international arbitration and valuation related court cases and also by the President of the Institute of Chartered Accountants.
He has significant experience in valuing all types of financial assets, including businesses, shares, complex financial instruments and intangible assets for a variety of purposes, including for M&A deals, restructuring, litigation, expert witness, business strategy, and tax and financial reporting. As part of Duff & Phelps he is able to offer an extended service assisting clients with sale mandates, litigation support, vendor due diligence, transfer pricing advice, business strategy, planning and modeling, commercial due diligence.
Duff & Phelps advised BioNTech AG on the collaboration deal with Pfizer
$130 million credit facility
November 1, 2018 London